Vera Therapeutics, Inc. Class A Common Stock

Go to Vera Therapeutics, Inc. Class A Common Stock Website

$20.00

-0.45 (-2.20%)
Live
Previous Close

$20.45

Day Range

$20.5 - $21.61

Previous Day Range

$19.84 - $20.795

Market Cap

$1.3 billion USD

Day Vol.

2.5 million

Previous Day Vol.

1.1 million

Currency

USD

Primary Exchange

Nasdaq

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protei...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Vera Therapeutics granted stock options and restricted stock units to 15 new employees, with options to purchase 133,500 shares and RSUs for 73,695 shares, vesting over four years.

Related tickers: VERA.

Read Full Article

Analysts are bullish on several little-known biopharma stocks, including Kymera Therapeutics, Vera Therapeutics, and Rapport Therapeutics, due to promising drug candidates and strong financial positions.

Related tickers: KYMR, VERA, RAPP.

Read Full Article
Trending Tickers

Please sign in to view